Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOF) Short Interest Update

Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOF) was the target of a large increase in short interest during the month of December. As of December 31st, there was short interest totalling 492,300 shares, an increase of 11.7% from the December 15th total of 440,600 shares. Based on an average daily trading volume, of 400 shares, the short-interest ratio is currently 1,230.8 days.

Kyowa Kirin Price Performance

Shares of KYKOF stock remained flat at $13.28 on Friday. The company’s 50-day simple moving average is $15.65 and its 200-day simple moving average is $18.04. Kyowa Kirin has a twelve month low of $13.28 and a twelve month high of $22.21.

Kyowa Kirin Company Profile

Kyowa Kirin Co, Ltd. engages in the research, development, manufacturing, marketing, and import/export of pharmaceuticals for oncology, nephrology, central nervous system, and immunology therapeutic areas in Japan, the United States, rest of the Americas, Europe, Asia, and internationally. Its products include ALLELOCK, an antihistamine agent for patients with various types of allergies; CONIEL, a calcium channel blocker for hypertension and angina pectoris; Crysvita, a recombinant human monoclonal IgG1 antibody against the phosphaturic hormone fibroblast growth factor 23; ESPO, a glycoprotein and human erythropoietin; NESP, an erythropoiesis stimulating agent; and GRAN, a human colony-stimulating factor.